Intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy recalcitrant to conventional therapy.
Chronic idiopathic demyelinating polyneuropathy is an immunologically mediated disorder that may not respond to glucocorticoid therapy, cytotoxic or other immunosuppressive medications, or plasmapheresis. We have reported such a case in which the patient had sustained clinical improvement with the repeated administration of high doses of intravenous immunoglobulin.
Urval
K
K
Department of Pediatrics, University of South Florida, St. Petersburg.
Nelson
R P
RP
Cohen
S R
SR
Good
R A
RA
D002908:Chronic Disease; D003711:Demyelinating Diseases / Q000628:therapy*; D004351:Drug Resistance; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use
D016756:Immunoglobulins, Intravenous; D011241:Prednisone